PanGenomic Health (HAM:LL3) Retained Earnings : €-13.91 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is PanGenomic Health Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. PanGenomic Health's retained earnings for the quarter that ended in Sep. 2024 was €-13.91 Mil.

PanGenomic Health's quarterly retained earnings declined from Mar. 2024 (€-12.35 Mil) to Jun. 2024 (€-14.04 Mil) but then increased from Jun. 2024 (€-14.04 Mil) to Sep. 2024 (€-13.91 Mil).

PanGenomic Health's annual retained earnings declined from Dec. 2021 (€-2.07 Mil) to Dec. 2022 (€-10.41 Mil) and declined from Dec. 2022 (€-10.41 Mil) to Dec. 2023 (€-12.27 Mil).

PanGenomic Health Retained Earnings Historical Data

The historical data trend for PanGenomic Health's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health Retained Earnings Chart

PanGenomic Health Annual Data

Trend

Dec21

Dec22

Dec23

Retained Earnings

-2.07

-10.41

-12.27

PanGenomic Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Retained Earnings	Get a 7-Day Free Trial									-12.05	-12.27	-12.35	-14.04	-13.91

PanGenomic Health Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

PanGenomic Health (HAM:LL3) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

PanGenomic Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (HAM:LL3) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

LL3:Germany NARA:Canada

Address

3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9

Website

https://www.pangenomic.com

PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

PanGenomic Health Headlines

No Headlines